Reminder: Invitation to Roche ’s live audio webcast on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020

Source: Roche Investor Update - January 31, 2020 Category: Pharmaceuticals Source Type: news